Stay updated on BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedExpanded the Locations section to include a comprehensive list of trial sites across the United States and other regions. Added Revision: v3.3.3.SummaryDifference1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedNote added that PubMed-listed publications are auto-filled from PubMed and may not pertain to the study, and the revision label updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check47 days agoChange DetectedThe government funding operating status notice at the top was removed. The rest of the study details and links remain unchanged.SummaryDifference0.2%

- Check68 days agoChange DetectedThe updates appear to be minor UI/layout adjustments and copy edits on the Study Details page, with no changes to core content such as eligibility criteria, study endpoints, or the list of locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange DetectedUpgrade notice added: new government funding lapse notice with operating status and official sources; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check97 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

Stay in the know with updates to BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIBF 1120 Long-Term Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.